课题基金 / 基金详情

Cancer pharmacoepidemiology: a population-based assessment of the risks of prescription drugs in vulnerable populations

Cancer pharmacoepidemiology: a population-based assessment of the risks of prescription drugs in vulnerable populations
癌症药物流行病学：基于人群的弱势群体处方药风险评估
批准号：
313617
负责人：
Azoulay Laurent
金额：
$62.12万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-09-01 至 2019-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=313617&lang=en
关键词：
Cancer Drug Safety Electronic Patient Databases Epidemiology Pharmacoepidemiology Population Based Public Health

项目摘要

项目成果

Azoulay Laurent的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
<html> <body> <p> <strong>Overarching focus of the research program</strong> <br> </p> <p>Cancer pharmacoepidemiology is emerging as an area of great interest in the medical community. With the increased use of prescription drugs across all ages, th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SGLT-2 Inhibitors and Early Bladder Cancer Events: An International Multi-Centre Study
The use of highly prolactin-elevating antipsychotics and the risk of ovarian and endometrial cancer
The use of beta-blockers and the prevention of cancer-specific mortality
The use of glyburide and the risk of cancer in elderly patients with type 2 diabetes
海外基金